T-cadherin Cancer Research Results

T-cadherin, T-cadherin/CDH13: Click to Expand ⟱
Source:
Type:
T-cadherin, also known as cadherin 13 (CDH13), is a member of the cadherin family of cell adhesion molecules.
T-cadherin is often overexpressed in certain types of cancer, including breast, prostate, and ovarian cancer. This overexpression has been associated with tumor progression, metastasis, and poor patient outcomes.
Scientific Papers found: Click to Expand⟱
8679- MLT,    Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
- in-vitro, Pca, NA
Synergy↑, ROS↑, MMP↝, mitResp↓, T-cadherin↓, OXPHOS↓, Glycolysis↓, Pyro↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

ROS↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

mitResp↓, 1,   OXPHOS↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

Glycolysis↓, 1,  

Cell Death(tgid=5) ⓘ

Pyro↑, 1,  

Migration(tgid=13) ⓘ

T-cadherin↓, 1,  

Barriers & Transport(tgid=15) ⓘ

MMP↝, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Synergy↑, 1,  
Total Targets: 8

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: T-cadherin, T-cadherin/CDH13
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:896  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page